Peng Liang is the founder of Clover Biopharmaceuticals. Clover Biopharmaceuticals has raised $13M in total funding. Latest round: Series A.
Dr. Peng Liang is the co-founder, Chairman and President of Clover Biopharmaceuticals, a biotechnology company focused on developing novel and transformative biologic therapies. He oversees the company's vision to bring innovative biologic therapies to the world, leveraging its Trimer-Tag™ drug discovery platform and cGMP biomanufacturing capabilities.
Full founder directory · Investor directory · Company funding database · Fundraising library